Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Allison B Lardieri"'
Publikováno v:
ASAIO Journal. 66:1042-1047
The study investigated the safety and efficacy of two antithrombin III (ATIII) products in pediatric patients receiving extracorporeal membrane oxygenation (ECMO) by performing a retrospective analysis of patients who received either recombinant ATII
Antipsychotic Treatment of Delirium in Critically Ill Children: A Retrospective Matched Cohort Study
Autor:
Shari Simone, Jamie Tumulty, Sarah Edwards, Allison B Lardieri, Ana Lia Graciano, Omayma A. Kishk
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 24:204-213
OBJECTIVE To describe the use of pharmacologic treatment in critically ill children treated according to a delirium protocol and compare those treated with antipsychotics to those treated non-pharmacologically. METHODS The study included a retrospect
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 23:293-297
OBJECTIVES In 2011, approximately 1.7 million pediatric patients had a codeine-containing prescription filled at a US retail pharmacy. Numerous cases involving serious adverse effects or fatalities have been reported in children who have been prescri
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 22:385-393
OBJECTIVE The use of dietary supplements has increased and is associated with adverse effects. Indications for use include recreation, body image concerns, mood enhancement, or control of medical conditions. The risk of adverse effects may be enhance
Gastric lactobezoars are a result of the inability to digest milk and mucous. Formulas that contain high casein concentrations, medium triglyceride oils, or high caloric density can increase the risk of bezoar formation by decreasing gastric secretio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91d9b5f56de62b2e778093c3c455c37d
https://europepmc.org/articles/PMC6510517/
https://europepmc.org/articles/PMC6510517/
Autor:
Brent N. Reed, Allison B Lardieri, Benjamin Laliberte, Sandeep Devabhakthuni, Kristin Watson, Carissa M. Baker-Smith, Ayesha Ather
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 36:955-970
Peripartum cardiomyopathy (PPCM) is an uncommon, idiopathic complication of pregnancy associated with significant (10-30%) mortality. The disease occurs late in pregnancy or in the months following delivery, resulting in reduced systolic function and
Autor:
Lilly Yen, Kazeem A Oshikoya, Beena G. Sood, Debbie Avant, Allison B. Lardieri, Norman E. Fenn, Gerold T. Wharton, Edwin Doe, Carol Taketomo, Sara L. Van Driest, Ann W. McMahon, Phuong Lieu
Publikováno v:
Paediatric drugs. 21(1)
OBJECTIVES: Half of prescription drugs commonly given to children lack product labeling on pediatric safety, efficacy, and dosing. Two drugs most widely used off-label in pediatrics are azithromycin and fentanyl. We sought to determine the risk of se
Autor:
L. Kyle Walker, Omayma A. Kishk, Allison B Lardieri, Shari Simone, Ana Lia Graciano, Sarah Edwards, Jason W. Custer
Publikováno v:
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 18(6)
Objectives To examine the impact of an ICU bundle on delirium screening and prevalence and describe characteristics of delirium cases. Design Quality improvement project with prospective observational analysis. Setting Nineteen-bed PICU in an urban a
Publikováno v:
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 22(1)
OBJECTIVES Adult guidelines suggest an area under the curve/minimum inhibitory concentration (AUC/MIC) > 400 corresponds to a vancomycin trough serum concentration of 15 to 20 mg/L for methicillin-resistant Staphylococcus aureus infections, but obtai
Publikováno v:
The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 21(3)
OBJECTIVES: Because of increases in antimicrobial resistance, the use of vancomycin in late-onset sepsis has come under scrutiny. The primary outcome of this study was to determine if vancomycin for the treatment of late-onset sepsis in the neonatal